Plastic Porous Medical Devices Market Global Report 2026

The plastic porous medical devices market size has grown strongly in recent years. It will grow from $0.71 billion in 2025 to $0.76 billion in 2026 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to growing demand for minimally invasive medical devices, increasing prevalence of chronic diseases, rising adoption of advanced wound management products, expanding use of diagnostic devices, increasing focus on infection prevention.

The plastic porous medical devices market size is expected to see strong growth in the next few years. It will grow to $0.96 billion in 2030 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to growing demand for implantable medical components, increasing investment in advanced biomaterials, rising adoption of precision drug delivery systems, expanding demand for high-performance filtration technologies, increasing healthcare infrastructure development. Major trends in the forecast period include increasing adoption of high-porosity medical components, growing demand for advanced fluid management solutions, rising use of biocompatible porous polymer materials, expansion of contamination control technologies in medical devices, increasing development of customized porous medical components.

The growing emphasis on infection control measures is expected to drive the growth of the plastic porous medical devices market going forward. Infection control measures are strategies implemented by healthcare facilities to prevent the transmission of pathogens among patients and healthcare workers. Hospitals and clinics are placing greater emphasis on these measures as the increasing occurrence of healthcare-associated infections contributes to higher patient morbidity, mortality rates, and healthcare costs. Plastic porous medical devices aid infection control by facilitating controlled fluid drainage, improving tissue breathability, and minimizing bacterial growth on device surfaces. For instance, in January 2026, according to the Centers for Disease Control and Prevention, a US-based public health organization, approximately 1 in 31 hospital patients in the United States has at least one healthcare-associated infection on any given day. Therefore, the increasing emphasis on infection control measures is supporting the growth of the plastic porous medical devices market.

Key companies operating in the plastic porous medical devices market are focusing on developing advanced technologies, such as 3D-printed porous PEEK (Polyether Ether Ketone) interbody technology, to improve implant performance, enhance biological integration, and develop next-generation polymer-based medical solutions. 3D-printed porous PEEK interbody technology is an advanced additive manufacturing approach that produces patient-specific polymer implants with controlled, interconnected porous structures designed to support bone ingrowth, improve implant stability, and replicate natural bone-like mechanical characteristics. For example, in June 2025, Curiteva, a US-based medical device company, launched the Inspire Trabecular PEEK Standalone ALIF System, the first 3D-printed standalone PEEK implant featuring HAFUSE surface technology to promote cell attachment and bone integration. The implant includes a fully interconnected porous lattice structure that improves biological performance and enables enhanced biomechanical load sharing compared with conventional titanium implants.

In December 2023, EQT AB, a Sweden-based private equity investment and growth capital firm focused on healthcare, technology, and industrial sectors, acquired Zeus Company LLC for $3.4 billion. Through this acquisition, EQT aims to accelerate Zeus’s global manufacturing growth, enhance its research and product development capabilities, and address increasing demand for advanced porous polymer components used in catheter-based and structural heart procedures. Zeus Company LLC is a US-based manufacturer of extruded and expanded fluoropolymer tubing, including Aeos microporous expanded PTFE (ePTFE) membranes, ribbons, and tubing, as well as other plastic porous components utilized in cardiovascular, neurovascular, and structural heart medical devices.

Major companies operating in the plastic porous medical devices market report are Porex Corporation, Saint-Gobain Life Sciences, Wilbert Lee Gore & Associates Inc., Freudenberg Medical, Medtronic plc, Porvair Filtration Group, Cobetter Filtration Equipment Co. Ltd., Ahlstrom, Teleflex Incorporated, GenPore, Atex Technologies Inc., Interstate Specialty Products Inc., Poriferous LLC, Pore Technology Inc., Sansuk Industries.

North America was the dominant region in the plastic porous medical devices market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the plastic porous medical devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the plastic porous medical devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

This product will be delivered within 3-5 business days.